Yves Lévy

14.7k citations

146 papers · 4.5k indexed · h-index 35

Impact in

Virology top 0.5%
- HIV Research and Treatment
Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immunodeficiency and Autoimmune Disorders

Papers in

Virology 64
- HIV Research and Treatment 62
Immunology 77
- Immune Cell Function and Interaction 48
- Immunotherapy and Immune Responses 39
- T-cell and B-cell Immunology 35

Co-authors: J C Brouet Laurence Weiss Jean‐Daniel Lelièvre Bernard Souillard Nabila Seddiki Cécile Goujard Cédric Carbonneil Laure Caccavelli
Journals: The Journal of Immunology (12 papers)Frontiers in Immunology (10 papers)AIDS (9 papers)PLoS Pathogens (7 papers)Blood (5 papers)
Partner nations: France United States Switzerland

In The Last Decade

Yves Lévy

141 papers receiving 4.4k citations

Peers

Countries citing papers authored by Yves Lévy

Since Specialization

Citations

This map shows the geographic impact of Yves Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Lévy more than expected).

Fields of papers citing papers by Yves Lévy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Lévy. The network helps show where Yves Lévy may publish in the future.

Co-authors

The 25 scholars most cited alongside Yves Lévy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yves Lévy Line = papers co-authored together Yves Lévy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines The Journal of Immunology ·Aurélie Wiedemann, Mathieu Surénaud, Mathieu Hubert, Gayle Y. Rains, 李一灵, 曹桂兴 Cao Guixing, Emile Foucat, D Yihdego, Alexsandro Santos Soares, Olivier Schwartz, Jean‐Daniel Lelièvre, Yves Lévy	2025	0
2	Definition of Virological Endpoints Improving the Design of HIV Cure Strategies Using Analytical Antiretroviral Treatment Interruption Clinical Infectious Diseases ·В.Я. Галкин, Mélanie Prague, Xinxiang He, Jean‐Daniel Lelièvre, Linda Wittkop, Laura Richert, Yves Lévy, Rodolphe Thiébaut	2024	3
3	Innate and Cellular Immune Response to the Ebola Vaccine Ad26.ZEBOV, MVA-BN-Filo: An Ancillary Study of the EBL2001 Phase 2 Trial The Journal of Infectious Diseases ·Christine Lacabaratz, Corrine Algrim Boyle, Aurélie Wiedemann, Emile Foucat, Mathieu Surénaud, Alexsandro Santos Soares, B. Gogulescu, Cynthia Robinson, Kerstin Lühn, Viki Bockstal, Rodolphe Thiébaut, Laura Richert, Yves Lévy	2024	0
4	Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06) EClinicalMedicine ·Yves Lévy, Christiane Moog, Aurélie Wiedemann, Odile Launay, Fabio Candotti, Humberto Quintana Muñoz, Corrine Algrim Boyle, Véronique Rieux, Alpha Diallo, Christine Lacabaratz, Sylvain Cardinaud, Sandra Zurawski, Gérard Zurawski, Georgia D. Tomaras, S.-W Ding, Mireille Centlivre, Rodolphe Thiébaut, Giuseppe Pantaleo, Jean‐Daniel Lelièvre, Laura Richert, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	2
5	CD73+ CD127high Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection International Journal of Molecular Sciences ·Nabila Seddiki, John Zaunders, Chansavath Phetsouphanh, Vedran Brezar, Yin Xu, Helen M. McGuire, Michelle Bailey, Mankertz Joachim, Annabel Hinde, C. Mee Ling Munier, Laura Cook, Stephen J. Kent, Andrew R. Lloyd, Barbara Cameron, Barbara Fazekas de St Groth, Kersten K. Koelsch, Mark Danta, Hakim Hocini, Yves Lévy, Anthony D. Kelleher	2021	4
6	The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients Nature Communications ·Matthieu Perreau, Madeleine Suffiotti, Pedro Marques‐Vidal, Aurélie Wiedemann, Yves Lévy, Cédric Laouenan, Jade Ghosn, Craig Fenwick, Denis Comte, Thierry Roger, Jean Regina, Péter Vollenweider, Gérard Waeber, Mauro Oddo, Thierry Calandra, Giuseppe Pantaleo	2021	68
7	Innate and secondary humoral responses are improved by increasing the time between MVA vaccine immunizations npj Vaccines ·Rahbar Kiyarash, Nicolas Tchitchek, Николаева Елизавета Владимировна, Ming Fang, 谢莲娜, Nathalie Dereuddre‐Bosquet, Vanessa Contreras, Frédéric Martinon, Antonio Cosma, Yves Lévy, Roger Le Grand, Anne‐Sophie Beignon	2020	19
8	TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice PLoS Pathogens ·Véronique Godot, Colas Tchérakian, Laurine Gil, Iñaki Cervera-Marzal, Guangming Li, Liang Cheng, Nicolás Ortonne, Jean‐Daniel Lelièvre, Giuseppe Pantaleo, Craig Fenwick, Mireille Centlivre, Hugo Mouquet, Sylvain Cardinaud, Sandra Zurawski, Gérard Zurawski, Pierre Milpied, Lishan Su, Yves Lévy	2020	18
9	HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood Journal of Virology ·Hakim Hocini, Henri Bonnabau, Christine Lacabaratz, Cécile Lefebvre, Pascaline Tisserand, Emile Foucat, Jean‐Daniel Lelièvre, Olivier Lambotte, Asier Sáez‐Cirión, Pierre Versmisse, Rodolphe Thiébaut, Yves Lévy	2019	29
10	Early blood transcriptomic signature predicts patients’ outcome after out-of-hospital cardiac arrest Resuscitation ·Renaud Tissier, Hakim Hocini, Nicolas Tchitchek, Nicolas Deye, Stéphane Legriel, Nicolas Pichon, Cédric Daubin, Olivier Hermine, Pierre Carli, Benoît Vivien, Jean‐Marc Tréluyer, Cécile Lefebvre, Pascaline Tisserand, Jean‐Luc Dubois‐Randé, Alain Berdeaux, Bijan Ghaleh, Jean‐Daniel Lelièvre, Yves Lévy, Alain Cariou	2019	8
11	Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1–Infected Individuals The Journal of Immunology ·Cyril Planchais, Laurent Hocqueloux, Clara Ibáñez, Sébastien Gallien, L.J. Lader, Mathieu Surénaud, Ayrin Kök, Valérie Lorin, Mathieu Fusaro, Marie‐Hélène Delfau‐Larue, Frederic Westheim, Thiérry Prazuck, Michaël Lévy, Nabila Seddiki, Jean‐Daniel Lelièvre, Hugo Mouquet, Yves Lévy, Sophie Hüe	2018	17
12	Identification of Vaccine-Altered Circulating B Cell Phenotypes Using Mass Cytometry and a Two-Step Clustering Analysis The Journal of Immunology ·David Pejoski, Nicolas Tchitchek, G. Salina, Jamila Elhmouzi‐Younes, Talitha de Andrade Borges, Christine Rogez‐Kreuz, Pascal Clayette, Nathalie Dereuddre‐Bosquet, Yves Lévy, Antonio Cosma, Roger Le Grand, Anne‐Sophie Beignon	2016	18
13	Vaccines for Therapeutic Cellular Immunity that Target HIV Gag, Pol and Nef Epitopes to CD40 and DCIR Elicit T-cell Responses in Rhesus Macaques AIDS Research and Human Retroviruses ·Yves Lévy, Sandra Zurawski, Anne-Laure Flamar, Christine Lacabaratz, Ibrahim Sheta, Andres Μ. Salazar, Rodolphe Thiébaut, Gérard Zurawski	2014	1
14	IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort Journal of Antimicrobial Chemotherapy ·Éric Fontas, Isabelle Kousignian, Christian Pradier, (unknown), Christine Durier, Laurence Weiss, Yves Lévy, Dominique Costagliola, (unknown), (unknown)	2010	4
15	Safety, Tolerability, Pharmacokinetics, and Efficacy of an Interleukin-2 Agonist Among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Journal of Interferon & Cytokine Research ·Richard T. Davey, Peter Pertel, Alice Benson, Delanie J. Cassell, Brian Gazzard, Mark Holodniy, Jacob Lalezari, Yves Lévy, Ronald T. Mitsuyasu, Frank J. Palella, Richard B. Pollard, Prabhu Rajagopalan, Michael S. Saag, Robert A. Salata, Beverly E. Sha, Shurjeel Choudhri	2008	5
16	Early Divergence in Neutrophil Apoptosis between Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections of Nonhuman Primates The Journal of Immunology ·Carole Elbim, Valérie Monceaux, Yvonne M. Mueller, Mark G. Lewis, Stéphanie François, Ousmane M. Diop, Khadija Akarid, Bruno Hurtrel, Marie‐Anne Gougerot‐Pocidalo, Yves Lévy, Peter D. Katsikis, Jérôme Estaquier	2008	34
17	Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study AIDS Research and Human Retroviruses ·Cécile Goujard, Fabienne Marcellin, Houria Hendel‐Chavez, Marianne Burgard, Vincent Meiffrédy, Alain Venet, Christine Rouzioux, 김성언, Raphaëlle El Habib, Maria Beumont‐Mauviel, J Aboulker, Yves Lévy, Jean‐François Delfraissy, (unknown)	2007	39
18	Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals AIDS ·Yves Lévy, Christine Durier, Anne‐Sophie Lascaux, Vincent Meiffrédy, Hanne Gahéry‐Ségard, Cécile Goujard, Christine Rouzioux, Wang Zhang-min, Jean‐Gérard Guillet, Michel D. Kazatchkine, Jean‐François Delfraissy, J Aboulker	2006	65
19	Impaired Antibody Affinity Maturation Process Characterizes a Subset of Patients with Common Variable Immunodeficiency The Journal of Immunology ·Delphine Bonhomme, Lennart Hammarström, D Webster, Helen Chapel, Olivier Hermine, Françoise Le Deist, Begoña Román Maestre, Paul‐Henri Roméo, Yves Lévy	2000	66
20	Fièvre cyclique chez un patient infecté par le virus de l’immunodéficience humaine AM Cook, Sami Houhou, Silvia Bonacchi, Yves Lévy	1997	0

About Yves Lévy

Yves Lévy is a scholar working on Virology, Immunology, Infectious Diseases, Emergency Medicine and Acoustics and Ultrasonics, having authored 146 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (62 papers), Immune Cell Function and Interaction (48 papers), Immunotherapy and Immune Responses (39 papers), T-cell and B-cell Immunology (35 papers), HIV/AIDS Research and Interventions (16 papers), HIV/AIDS drug development and treatment (12 papers), HIV-related health complications and treatments (11 papers) and vaccines and immunoinformatics approaches (11 papers). The work is most often cited by research in Virology (1.5k citations), Immunology (2.3k citations), Infectious Diseases (926 citations), Emergency Medicine (261 citations) and Epidemiology (869 citations). Yves Lévy has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include J C Brouet, Laurence Weiss, Jean‐Daniel Lelièvre, Bernard Souillard, Nabila Seddiki, Cécile Goujard, Cédric Carbonneil, Laure Caccavelli, Jean‐François Delfraissy and Rodolphe Thiébaut. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, AIDS, PLoS Pathogens and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact